The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes

Summary:  Immunodominance refers to the restricted antigen specificity of T cells detected in the immune response after immunization with complex antigens. Despite the presence of many potential peptide epitopes within these immunogens, the elicited T‐cell response apparently focuses on a very limited number of peptides. Over the last two decades, a number of distinct explanations have been put forth to explain this very restricted specificity of T cells, many of which suggest that endosomal antigen processing restricts the array of peptides available to recruit CD4 T cells. In this review, we present evidence from our laboratory that suggest that immunodominance in CD4 T‐cell responses is primarily due to an intrinsic property of the peptide:class II complexes. The intrinsic kinetic stability of peptide:class II complexes controls DM editing within the antigen‐presenting cells and thus the initial epitope density on priming dendritic cells. Additionally, we hypothesize that peptides that possess high kinetic stability interactions with class II molecules display persistence at the cell surface over time and will more efficiently promote T‐cell signaling and differentiation than competing, lower‐stability peptides contained within the antigen. We discuss this model in the context of the existing data in the field of immunodominance.

[1]  Francisco A. Chaves,et al.  The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance. , 2005, Immunity.

[2]  Francisco A. Chaves,et al.  Replacement of the membrane proximal region of I-A(d) MHC class II molecule with I-E-derived sequences promotes production of an active and stable soluble heterodimer without altering peptide-binding specificity. , 2005, Journal of immunological methods.

[3]  Henry C. Chang,et al.  Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen Fate , 2005, Science.

[4]  T. Tuschl,et al.  Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy , 2005, Science.

[5]  B. Kyewski,et al.  Regulating self-tolerance by deregulating gene expression. , 2004, Current opinion in immunology.

[6]  Michael D. Cahalan,et al.  Imaging the Single Cell Dynamics of CD4+ T Cell Activation by Dendritic Cells in Lymph Nodes , 2004, The Journal of experimental medicine.

[7]  Philip J Norris,et al.  A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Kyewski,et al.  Self-representation in the thymus: an extended view , 2004, Nature Reviews Immunology.

[9]  F. Koning,et al.  Dissection of the HLA-DR4 Peptide Repertoire in Endocrine Epithelial Cells: Strong Influence of Invariant Chain and HLA-DM Expression on the Nature of Ligands1 , 2004, The Journal of Immunology.

[10]  S. Sadegh-Nasseri,et al.  The Magnitude of TCR Engagement Is a Critical Predictor of T Cell Anergy or Activation1 , 2004, The Journal of Immunology.

[11]  C. Benoist,et al.  Good riddance: Thymocyte clonal deletion prevents autoimmunity. , 2004, Current opinion in immunology.

[12]  B. Evavold,et al.  Degenerate recognition of T cell epitopes: impact of T cell receptor reserve and stability of peptide:MHC complexes. , 2004, Molecular immunology.

[13]  Mark J. Miller,et al.  T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  D. Wiley,et al.  Enhanced Catalytic Action of HLA-DM on the Exchange of Peptides Lacking Backbone Hydrogen Bonds between their N-Terminal Region and the MHC Class II α-Chain1 , 2004, The Journal of Immunology.

[15]  S. Henrickson,et al.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases , 2004, Nature.

[16]  B. Evavold,et al.  Modification of peptide interaction with MHC creates TCR partial agonists. , 2004, Cellular immunology.

[17]  E. Unanue,et al.  Cutting Edge: H-2DM Is Responsible for the Large Differences in Presentation Among Peptides Selected by I-Ak During Antigen Processing 1 , 2003, The Journal of Immunology.

[18]  Pamela S. Ohashi,et al.  TCR Binding Kinetics Measured with MHC Class I Tetramers Reveal a Positive Selecting Peptide with Relatively High Affinity for TCR 1 , 2003, The Journal of Immunology.

[19]  Antonio Lanzavecchia,et al.  Regulation of Dendritic Cell Migration to the Draining Lymph Node , 2003, The Journal of experimental medicine.

[20]  A. Sette,et al.  Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. , 2003, Current opinion in immunology.

[21]  M. Jenkins,et al.  Antigen presentation to naive CD4 T cells in the lymph node , 2003, Nature Immunology.

[22]  J. Elliott,et al.  Editing of an Immunodominant Epitope of Glutamate Decarboxylase by HLA-DM1 , 2003, The Journal of Immunology.

[23]  Mark M Davis,et al.  Continuous T cell receptor signaling required for synapse maintenance and full effector potential , 2003, Nature Immunology.

[24]  A. Rudensky,et al.  Lysosomal cysteine proteases regulate antigen presentation , 2003, Nature Reviews Immunology.

[25]  H. Reijonen,et al.  Low‐avidity recognition by CD4+ T cells directed to self‐antigens , 2003, European journal of immunology.

[26]  Chad H. Koonce,et al.  DM Loss in k Haplotype Mice Reveals Isotype-Specific Chaperone Requirements 1 , 2003, The Journal of Immunology.

[27]  Antonio Lanzavecchia,et al.  T cell fitness determined by signal strength , 2003, Nature Immunology.

[28]  H. Reijonen,et al.  Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes. , 2003, Methods.

[29]  Philippa Marrack,et al.  Epitope dominance, competition and T cell affinity maturation. , 2003, Current opinion in immunology.

[30]  Ccggaattccatcacgtgttcgtggagact Tgtaaaacgacggccagtgc,et al.  Second Class Minors : Molecular Identification of the Autosomal H 46 Histocompatibility Locus as a Peptide Presented by Major Histocompatibility Complex Class II Molecules , 2003 .

[31]  F. Sallusto,et al.  Opinion-decision making in the immune system: Progressive differentiation and selection of the fittest in the immune response , 2002, Nature Reviews Immunology.

[32]  K. Wucherpfennig,et al.  Structural Factors Contributing to DM Susceptibility of MHC Class II/Peptide Complexes1 , 2002, The Journal of Immunology.

[33]  N. L. La Gruta,et al.  The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues , 2002, The Journal of Immunology.

[34]  Mark S. Anderson,et al.  Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein , 2002, Science.

[35]  L. Turka,et al.  The Proliferative Capacity of Individual Naive CD4+T Cells Is Amplified by Prolonged T Cell Antigen Receptor Triggering , 2002, The Journal of experimental medicine.

[36]  E. Ingulli,et al.  In Situ Analysis Reveals Physical Interactions Between CD11b+ Dendritic Cells and Antigen-Specific CD4 T Cells After Subcutaneous Injection of Antigen1 , 2002, The Journal of Immunology.

[37]  R. Locksley,et al.  Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo. , 2002, Immunity.

[38]  David L. Woodland,et al.  The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues1 , 2002, The Journal of Immunology.

[39]  E. Unanue,et al.  Cutting Edge: Chemical Dominance Does Not Relate to Immunodominance: Studies of the CD4+ T Cell Response to a Model Antigen , 2002, The Journal of Immunology.

[40]  H. Ploegh,et al.  A closer look at proteolysis and MHC-class-II-restricted antigen presentation. , 2002, Current opinion in immunology.

[41]  N. Viner,et al.  Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP , 2002, Nature Immunology.

[42]  N. K. Steede,et al.  Structural Basis for Helper T-cell and Antibody Epitope Immunodominance in Bacteriophage T4 Hsp10 , 2002, Journal of Biological Chemistry.

[43]  Laurence Zitvogel,et al.  Antigen presentation and T cell stimulation by dendritic cells. , 2002, Annual review of immunology.

[44]  L. Klein,et al.  Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self , 2001, Nature Immunology.

[45]  L. Qi,et al.  H2-O Inhibits Presentation of Bacterial Superantigens, but Not Endogenous Self Antigens1 , 2001, The Journal of Immunology.

[46]  A. Sant,et al.  Energetic asymmetry among hydrogen bonds in MHC class II⋅peptide complexes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Blum,et al.  Cutting Edge: Editing of Recycling Class II:Peptide Complexes by HLA-DM1 , 2001, The Journal of Immunology.

[48]  Maria V. Tejada-Simon,et al.  Naturally Processed HLA Class II Peptides Reveal Highly Conserved Immunogenic Flanking Region Sequence Preferences That Reflect Antigen Processing Rather Than Peptide-MHC Interactions1 , 2001, The Journal of Immunology.

[49]  S. Jameson,et al.  A Low Affinity TCR Ligand Restores Positive Selection of CD8+ T Cells In Vivo1 , 2001, The Journal of Immunology.

[50]  F. Sallusto,et al.  Antigen decoding by T lymphocytes: from synapses to fate determination , 2001, Nature Immunology.

[51]  Chad H. Koonce,et al.  Relaxed DM Requirements During Class II Peptide Loading and CD4+ T Cell Maturation in BALB/c Mice1 , 2001, The Journal of Immunology.

[52]  C. Watts,et al.  Antigen processing in the endocytic compartment. , 2001, Current opinion in immunology.

[53]  C. Nelson,et al.  Structural and Functional Consequences of Altering a Peptide MHC Anchor Residue , 2001 .

[54]  A. Khoruts,et al.  In vivo activation of antigen-specific CD4 T cells. , 2001, Annual review of immunology.

[55]  Scheherazade Sadegh-Nasseri,et al.  Hla-Dm Recognizes the Flexible Conformation of Major Histocompatibility Complex Class II , 2000, The Journal of experimental medicine.

[56]  J. Kappler,et al.  T Cell Receptor (Tcr)-Mediated Repertoire Selection and Loss of Tcr Vβ Diversity during the Initiation of a Cd4+ T Cell Response in Vivo , 2000, The Journal of experimental medicine.

[57]  A. Smith,et al.  Visualizing T cell competition for peptide/MHC complexes: a specific mechanism to minimize the effect of precursor frequency. , 2000 .

[58]  Philippa Marrack,et al.  T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells , 2000, The Journal of experimental medicine.

[59]  A. Sant,et al.  Dm Determines the Cryptic and Immunodominant Fate of T Cell Epitopes , 2000, The Journal of experimental medicine.

[60]  P. Cresswell,et al.  Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. , 2000, The Journal of biological chemistry.

[61]  E. Sercarz,et al.  Cutting Edge: Introduction of an Endopeptidase Cleavage Motif into a Determinant Flanking Region of Hen Egg Lysozyme Results in Enhanced T Cell Determinant Display1 , 2000, The Journal of Immunology.

[62]  B. Chain,et al.  Protein degradation in MHC class II antigen presentation: opportunities for immunomodulation. , 2000, Seminars in Cell and Developmental Biology.

[63]  B. Evavold,et al.  DO11.10 and OT-II T Cells Recognize a C-Terminal Ovalbumin 323–339 Epitope1 , 2000, The Journal of Immunology.

[64]  S. Landry Helper T-cell epitope immunodominance associated with structurally stable segments of hen egg lysozyme and HIV gp120. , 2000, Journal of theoretical biology.

[65]  L. Karlsson,et al.  Nonclassical MHC class II molecules. , 2000, Annual review of immunology.

[66]  D. Zaller,et al.  Role of APC in the selection of immunodominant T cell epitopes. , 1999, Journal of immunology.

[67]  T. Lybrand,et al.  Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers. , 1999, Biochemistry.

[68]  G. Hämmerling,et al.  The impact of the non‐classical MHC proteins HLA‐DM and HLA‐DO on loading of MHC class II molecules , 1999, Immunological reviews.

[69]  G. Hämmerling,et al.  Quality control of MHC class II associated peptides by HLA-DM/H2-M. , 1999, Seminars in immunology.

[70]  S. Ceman,et al.  Individual hydrogen bonds play a critical role in MHC class II:peptide interactions: implications for the dynamic aspects of class II trafficking and DM‐mediated peptide exchange , 1999, Immunological reviews.

[71]  J. Borghans,et al.  Competition for antigenic sites during T cell proliferation: a mathematical interpretation of in vitro data. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[72]  S. Tompkins,et al.  Assessment of the role of determinant selection in genetic control of the immune response to insulin in H-2b mice. , 1999, Journal of immunology.

[73]  P. Marrack,et al.  An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[74]  J. Panus,et al.  Evolution of Antigen-specific T Cell Receptors In Vivo: Preimmune and Antigen-driven Selection of Preferred Complementarity-determining Region 3 (CDR3) Motifs , 1999, The Journal of experimental medicine.

[75]  P. Allen,et al.  A Kinetic Threshold between Negative and Positive Selection Based on the Longevity of the T Cell Receptor–Ligand Complex , 1999, The Journal of experimental medicine.

[76]  G. Hämmerling,et al.  Identification of destabilizing residues in HLA class II‐selected bacteriophage display libraries edited by HLA‐DM , 1999, European journal of immunology.

[77]  Jason G. Cyster,et al.  Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs , 1999, The Journal of experimental medicine.

[78]  P. Fairchild,et al.  Reversal of immunodominance among autoantigenic T-cell epitopes. , 1999, Autoimmunity.

[79]  J. Yewdell,et al.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.

[80]  D. Weber,et al.  HLA-DM and the MHC class II antigen presentation pathway , 1999, Immunologic research.

[81]  M. Mcgrath The lysosomal cysteine proteases. , 1999, Annual review of biophysics and biomolecular structure.

[82]  E. Sercarz,et al.  Heterogeneity of the T cell response to immunodominant determinants within hen eggwhite lysozyme of individual syngeneic hybrid F1 mice: implications for autoimmunity and infection. , 1998, Journal of immunology.

[83]  D. Hanahan,et al.  Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. , 1998, Current opinion in immunology.

[84]  C. Benoist,et al.  The phenotype of H‐2M‐deficient mice is dependent on the MHC class II molecules expressed , 1998, European journal of immunology.

[85]  E. Ingulli,et al.  Visualization of specific B and T lymphocyte interactions in the lymph node. , 1998, Science.

[86]  Paul V. Lehmann,et al.  Endogenous Myelin Basic Protein Inactivates the High Avidity T Cell Repertoire , 1998, The Journal of experimental medicine.

[87]  E. Sercarz,et al.  Modulation of the immunogenicity of antigenic determinants by their flanking residues. , 1998, Immunology today.

[88]  T. Hunkapiller,et al.  Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. , 1998, Immunity.

[89]  H. Grey,et al.  The role of peptides in thymic positive selection of class II major histocompatibility complex-restricted T cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[90]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[91]  P. A. Peterson,et al.  Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.

[92]  J. Cabaniols,et al.  Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model. , 1998, Journal of immunology.

[93]  M. Hofnung,et al.  Immunodominance does not result from peptide competition for MHC class II presentation. , 1998, Journal of immunology.

[94]  A. Rudensky,et al.  Invariant Chain–independent Function of H-2M in the Formation of Endogenous Peptide–Major Histocompatibility Complex Class II Complexes In Vivo , 1998, The Journal of experimental medicine.

[95]  A. Lanzavecchia,et al.  The duration of antigenic stimulation determines the fate of naive and effector T cells. , 1998, Immunity.

[96]  E. Sercarz,et al.  Immunodominance is independent of structural constraints: each region within hen eggwhite lysozyme is potentially available upon processing of native antigen. , 1997, Journal of immunology.

[97]  D. Vignali,et al.  T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. , 1997, Immunity.

[98]  J. McCluskey,et al.  Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines. , 1997, International immunology.

[99]  R. Lechler,et al.  In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[100]  G. Hämmerling,et al.  How HLA-DM affects the peptide repertoire bound to HLA-DR molecules. , 1997, Human immunology.

[101]  J. Cabaniols,et al.  Determinant selection for T-cell tolerance in HEL-transgenic mice: dissociation between immunogenicity and tolerogenicity. , 1997, Cellular immunology.

[102]  E. Unanue,et al.  Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway. , 1997, Journal of immunology.

[103]  J. Blum,et al.  Antigen-presenting cells and the selection of immunodominant epitopes. , 1997, Critical reviews in immunology.

[104]  A. Sant,et al.  DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules. , 1996, Journal of immunology.

[105]  P. Cresswell,et al.  HLA-DM Interactions with Intermediates in HLA-DR Maturation and a Role for HLA-DM in Stabilizing Empty HLA-DR Molecules , 1996, The Journal of experimental medicine.

[106]  G. Hämmerling,et al.  Editing of the HLA‐DR‐peptide repertoire by HLA‐DM. , 1996, The EMBO journal.

[107]  J. Trowsdale,et al.  Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs , 1996, The Journal of experimental medicine.

[108]  A. Sant,et al.  Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules , 1996, The Journal of experimental medicine.

[109]  B. Evavold,et al.  Enhanced Dissociation of HLA-DR-Bound Peptides in the Presence of HLA-DM , 1996, Science.

[110]  T. Watts,et al.  Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells. , 1996, Journal of immunology.

[111]  G. Hämmerling,et al.  Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[112]  E. Unanue,et al.  Appreciating the Complexity of MHC Class II Peptide Binding: Lysozyme Peptide and I‐Ak , 1996, Immunological reviews.

[113]  E. Sercarz,et al.  Antigen processing and T cell repertoires as crucial aleatory features in induction of autoimmunity. , 1996, Journal of autoimmunity.

[114]  J. Altman,et al.  Tracking antigen-specific helper T cell responses. , 1996, Current opinion in immunology.

[115]  C. Benoist,et al.  Mice Lacking H2-M Complexes, Enigmatic Elements of the MHC Class II Peptide-Loading Pathway , 1996, Cell.

[116]  H. Ruley,et al.  H2-M Mutant Mice Are Defective in the Peptide Loading of Class II Molecules, Antigen Presentation, and T Cell Repertoire Selection , 1996, Cell.

[117]  R. Busch,et al.  Developing and shedding inhibitions: how MHC class II molecules reach maturity. , 1996, Current opinion in immunology.

[118]  D. Wraith,et al.  Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC. , 1996, Immunology today.

[119]  S. Tonegawa,et al.  Presentation of endogenous viral proteins in association with major histocompatibility complex class II: On the role of intracellular compartmentalization, invariant chain and the TAP transporter system , 1995, European journal of immunology.

[120]  P. Reay,et al.  Mechanisms of T cell epitope immunodominance analyzed in murine listeriosis. , 1995, Journal of immunology.

[121]  D. Kioussis,et al.  Low avidity recognition of self-antigen by T cells permits escape from central tolerance. , 1995, Immunity.

[122]  D. Weber,et al.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.

[123]  P. Cresswell,et al.  HLA-DM induces clip dissociation from MHC class II αβ dimers and facilitates peptide loading , 1995, Cell.

[124]  D. Zaller,et al.  Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.

[125]  R. Locksley,et al.  Expression cloning of a protective Leishmania antigen. , 1995, Science.

[126]  A. Chervonsky,et al.  The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent , 1995, The Journal of experimental medicine.

[127]  P. Cresswell,et al.  HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. , 1995, Cell.

[128]  P. L. Campbell,et al.  Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes. , 1994, Journal of immunology.

[129]  P. A. Peterson,et al.  Reconstitution of an operational MHC class II compartment in nonantigen-presenting cells. , 1994, Science.

[130]  K. Wucherpfennig Autoimmunity in the central nervous system: mechanisms of antigen presentation and recognition. , 1994, Clinical immunology and immunopathology.

[131]  A. Finnegan,et al.  Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo. , 1994, Journal of immunology.

[132]  M. Hofnung,et al.  Molecular context of a viral T cell determinant within a chimeric bacterial protein alters the diversity of its T cell recognition. , 1994, Journal of immunology.

[133]  Eric O Long,et al.  Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. , 1994, Journal of immunology.

[134]  B. Arp,et al.  HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells , 1994, Nature.

[135]  Jeffrey A. Shaman,et al.  An essential role for HLA–DM in antigen presentation by class II major histocompatibility molecules , 1994, Nature.

[136]  Kristin A. Hogquist,et al.  T cell receptor antagonist peptides induce positive selection , 1994, Cell.

[137]  A. Sant Endogenous antigen presentation by MHC class II molecules , 1994, Immunologic research.

[138]  M. Hofnung,et al.  Induction of T cell responses by chimeric bacterial proteins expressing several copies of a viral T cell epitope , 1993, European journal of immunology.

[139]  J. Smith,et al.  Immunodominance: a single amino acid substitution within an antigenic site alters intramolecular selection of T cell determinants. , 1993, Journal of immunology.

[140]  E. Sercarz,et al.  The involvement of antigen processing in determinant selection by class II MHC and its relationship to immunodominance , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[141]  G. Loss,et al.  Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways , 1993, The Journal of experimental medicine.

[142]  William Arbuthnot Sir Lane,et al.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles , 1993, The Journal of experimental medicine.

[143]  R. Locksley,et al.  TH1 and TH2 cell antigen receptors in experimental leishmaniasis. , 1993, Science.

[144]  A. Miller,et al.  Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.

[145]  C. Rabourdin-Combe,et al.  High efficiency of endogenous antigen presentation by MHC class II molecules. , 1992, International immunology.

[146]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[147]  Eric O Long,et al.  Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells , 1992, Nature.

[148]  M. Hofnung,et al.  Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. , 1992, Gene.

[149]  M. Hofnung,et al.  Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. , 1992, Gene.

[150]  J. Cabaniols,et al.  Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[151]  L. Smith,et al.  A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex , 1991, The Journal of experimental medicine.

[152]  K. Rock,et al.  The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors. , 1991, Journal of immunology.

[153]  M. Davis,et al.  Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH , 1991, The Journal of experimental medicine.

[154]  J. McCluskey,et al.  Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[155]  E. Sercarz,et al.  T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes , 1991, The Journal of experimental medicine.

[156]  A. Taylor,et al.  Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice , 1991, Journal of virology.

[157]  M. Bekoff,et al.  Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[158]  F. Cardinaux,et al.  In vivo competition between self peptides and foreign antigens in T-cell activation , 1988, Nature.

[159]  K. Cease,et al.  Influences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing , 1988, The Journal of experimental medicine.

[160]  R. Titus,et al.  Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice. , 1986, Journal of immunology.

[161]  J. Berzofsky,et al.  T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance. , 1985, Journal of immunology.

[162]  J. Berzofsky,et al.  Identification of distinct predominant epitopes recognized by myoglobin-specific T cells under the control of different Ir genes and characterization of representative T cell clones. , 1984, Journal of immunology.

[163]  A Wlodawer,et al.  The refined crystal structure of ribonuclease A at 2.0 A resolution. , 1982, The Journal of biological chemistry.